07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CIMRP<br />

88804<br />

CBUR<br />

82802<br />

Negative<br />

If positive, results are titered.<br />

IMMUNODIFFUSION<br />

Negative<br />

Results are reported as positive, negative, or equivocal.<br />

Clinical References: Larone D, Mitchell T, Walsh T: Histoplasma, blastomyces, coccidioides, and<br />

other dimorphic fungi causing systemic mycoses. In Manual of Clinical Microbiology. 7th edition. Edited<br />

by PR Murray, EJ Baron, MA Pfaller, et al: Washington, DC, ASM Press, 1999, pp 1260-1261<br />

Coccidioides immitis/posadasii, Molecular Detection, PCR<br />

Clinical Information: Coccidioidomycosis is caused by the dimorphic fungi, Coccidioides immitis<br />

and Coccidioides posadasii. These organisms are endemic to the southwestern regions of the United<br />

States, northern Mexico, and areas of Central and South America. The illness commonly manifests as a<br />

self-limited upper respiratory tract infection, but can also result in disseminated disease that may be<br />

refractory to treatment.(1) Clinical onset generally occurs 10 to 16 days following inhalation of<br />

coccidioidal spores (arthroconidia).(2) Disease progression may be rapid in previously healthy or<br />

immunosuppressed individuals. At present, the gold standard for the diagnosis of coccidioidomycosis is<br />

culture of the organism from clinical specimens. Culture is highly sensitive and, with the implementation<br />

of DNA probe assays for confirmatory testing of culture isolates, yields excellent specificity.(3) However,<br />

growth in culture may take up to several weeks. This often delays the diagnosis and treatment of infected<br />

individuals. In addition, the propagation of Coccidioides species in the clinical laboratory is a significant<br />

safety hazard to laboratory personnel, serving as an important cause of laboratory-acquired infections if<br />

the organism is not quickly identified and handled appropriately (ie, in a Biosafety Level 3 facility).<br />

Serological tests including immunodiffusion and complement fixation are widely used for the detection of<br />

antibody against Coccidioides. Serology for Coccidioides can be limited by delays in antibody<br />

development or nonspecificity due to cross-reactions with other fungi. In addition, immunodiffusion and<br />

complement fixation tests are highly labor intensive and are generally limited to reference laboratories.<br />

Molecular methods can identify Coccidioides species directly from clinical specimens, avoiding the need<br />

for culture and allowing for a more rapid and safer diagnosis.<br />

Useful For: Rapid detection of Coccidioides An aid in diagnosing coccidioidomycosis<br />

Interpretation: A positive result indicates presence of Coccidioides DNA. A negative result indicates<br />

absence of detectable Coccidioides DNA.<br />

Reference Values:<br />

Not applicable<br />

Clinical References: 1. Chiller TM, Galgiani JN, Stevens DA: Coccidioidomycosis. Infect Dis Clin<br />

North Am 2003;17:41-57 2. Feldman BS, Snyder LS: Primary pulmonary coccidioidomycosis. Semin<br />

Respir Infect 2001;16:231-237 3. Padhye AA, Smith G, Standard, et al: Comparative evaluation of<br />

chemiluminescent DNA probe assays and exoantigen tests for rapid identification of Blastomyces<br />

dermatitis and Coccidioides immitis. J Clin Microbiol 1994;32:867-870 4. Inoue T, Nabeshima K,<br />

Kataoka H, Koono M: Feasibility of archival non-buffered formalin-fixed and paraffin-embedded tissues<br />

for PCR amplification: an analysis of resected gastric carcinoma. Pathol Int 1996;46:997-1004<br />

Cocklebur, IgE<br />

Clinical Information: Clinical manifestations of immediate hypersensitivity (allergic) diseases are<br />

caused by the release of proinflammatory mediators (histamine, leukotrienes, and prostaglandins) from<br />

immunoglobulin E (IgE)-sensitized effector cells (mast cells and basophils) when cell-bound IgE<br />

antibodies interact with allergen. In vitro serum testing for IgE antibodies provides an indication of the<br />

immune response to allergen(s) that may be associated with allergic disease. The allergens chosen for<br />

testing often depend upon the age of the patient, history of allergen exposure, season of the year, and<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 499

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!